Table 6.
All participants’ responses (mean, SD), according to ‘may affect’ or ‘will affect’ risk qualifier terms
| Format | anova F‐value (P) | |||||
|---|---|---|---|---|---|---|
| ‘May affect’ risk qualifier | ‘Will affect’ risk qualifier | Relative risk estimate increase: ‘may affect’ > ‘will affect’ | ||||
| M (SD) | n | M | (SD) n | |||
| Side‐effect risk estimates (actual %) | ||||||
| Chance of aching joints & muscles (60%) | 18.9 (23.2) | 144 | 17.2 (19.7) | 126 | +9.9% | 0.44 (0.51) |
| Chance of severe anaemia (6%) | 13.3 (15.2) | 150 | 12.6 (13.4) | 133 | +12.3% | 0.17 (0.68) |
| Chance of serious allergic reaction (0.1–1%) | 3.6 (10.2) | 148 | 2.8 (7.4) | 136 | +24.9% | 0.52 (0.47) |
| Chance of itching (0.01–0.1%) | 3.4 (12.7) | 145 | 3.5 (12.8) | 131 | −3.7% | 0.01 (0.94) |
| Chance of dizziness or fits (<0.01%) | 2.2 (10.5) | 143 | 2.6 (10.7) | 127 | −16.3% | 0.10 (0.75) |
| Chance of ANY side‐effect | 25.9 (27.4) | 144 | 23.9 (25.3) | 125 | +8.4% | 0.38 (0.54) |
| Likert scale items | ||||||
| Satisfaction with side‐effect information | 4.4 (1.3) | 165 | 4.3 (1.3) | 149 | 0.20 (0.66) | |
| How bad overall are Taxol side‐effects | 3.5 (1.1) | 165 | 3.2 (1.0) | 160 | 5.26 (0.022) | |
| Likelihood of having a side‐effect | 3.7 (1.4) | 165 | 3.6 (1.4) | 149 | 0.60 (0.43) | |
| General risk to health from Taxol | 3.2 (1.0) | 164 | 3.1 (1.0) | 150 | 0.26 (0.61) | |
| Impact of information on decision to take Taxol | 2.9 (1.4) | 164 | 2.7 (1.5) | 149 | 1.51 (0.22) | |
Bold text indicates statistical significance (p <.05).